Literature DB >> 28121241

Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies.

S Wei1, K Lai1, Z Yang1, K Zeng1.   

Abstract

We performed a meta-analysis to identify the association between systemic lupus erythematosus (SLE) and preterm birth. In this study, we studied the effects of SLE, SLE disease activity, a history of nephritis and active nephritis on preterm birth. Searches were conducted before 20 May 2016 of PubMed, Embase, Medline and Cochrane Library of literature and article reference lists. Eleven observational case-control studies and thirteen cohort studies met the inclusion criteria. The pooled relative risk (RR) for the risk of preterm birth in SLE patients versus controls was 2.05 (95% confidence interval (CI): 1.72-3.32); for active SLE patients versus inactive was 2.98 (95% CI: 2.32-3.83); for SLE patients with a history of lupus nephritis versus those without nephritis it was 1.62 (95% CI: 1.35-1.95); and for SLE patients with active nephritis versus those with quiescent nephritis it was 1.78 (95% CI: 1.17-2.70). In summary, this study identified a significant association in the above results. This association was more significant in active SLE patients versus inactive. With respect to SLE itself, active inflammation (such as disease activity) may be more hazardous for the management of the pregnancy. This suggests that it is essential to control disease activity in order to achieve a better outcome of SLE pregnancy.

Entities:  

Keywords:  Systemic lupus erythematosus; disease activity; lupus nephritis; preterm birth

Mesh:

Year:  2017        PMID: 28121241     DOI: 10.1177/0961203316686704

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  23 in total

1.  Asthma in Children of Mothers With Systemic Lupus Erythematosus and the Role of Preterm Birth.

Authors:  Marios Rossides; Cathina Nguyen; Elizabeth V Arkema; Julia F Simard
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-03       Impact factor: 4.794

2.  Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.

Authors:  K D Kolstad; J A Mayo; L Chung; Y Chaichian; V M Kelly; M Druzin; D K Stevenson; G M Shaw; J F Simard
Journal:  BJOG       Date:  2019-10-31       Impact factor: 6.531

3.  Oral corticosteroid use during pregnancy and risk of preterm birth.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Min Xi; Diana L Johnson; Ronghui Xu; Christina D Chambers
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

4.  Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study.

Authors:  A M Eudy; D Voora; R A Myers; M E B Clowse
Journal:  Lupus       Date:  2019-11-04       Impact factor: 2.911

5.  [Pregnancy and rheumatic diseases].

Authors:  R Fischer-Betz; S Späthling-Mestekemper
Journal:  Z Rheumatol       Date:  2020-02       Impact factor: 1.372

6.  Clinical practice guideline on pregnancy and renal disease.

Authors:  Kate Wiles; Lucy Chappell; Katherine Clark; Louise Elman; Matt Hall; Liz Lightstone; Germin Mohamed; Durba Mukherjee; Catherine Nelson-Piercy; Philip Webster; Rebecca Whybrow; Kate Bramham
Journal:  BMC Nephrol       Date:  2019-10-31       Impact factor: 2.388

7.  Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome.

Authors:  Merlijn Wind; Maike Hendriks; Marieke Sueters; Y K Onno Teng; Bernadette T J van Brussel; Jeroen Eikenboom; Cornelia F Allaart; Hildo J Lamb; Hans-Marc J Siebelink; Maarten K Ninaber; Nan van Geloven; Jan M M van Lith; Tom W J Huizinga; Ton J Rabelink
Journal:  Lupus Sci Med       Date:  2021-05

8.  The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus.

Authors:  Katarina Bremme; Sonja Honkanen; Iva Gunnarsson; Roza Chaireti
Journal:  Lupus       Date:  2021-04-12       Impact factor: 2.911

Review 9.  Rheumatologic Medication Use During Pregnancy.

Authors:  Emily A Peterson; Jessica Lynton; Allison Bernard; Mark K Santillan; Brittany Bettendorf
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.661

10.  Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program.

Authors:  Kristin Palmsten; Gretchen Bandoli; Jim Watkins; Gabriela Vazquez-Benitez; Todd P Gilmer; Christina D Chambers
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.